Thursday, 28 November 2024
FIRST SESSION
New biomarkers for tuberculosis diagnosis
Delia Goletti (Italy)
Tuberculosis and COVID interaction
Giovanni Battista Migliori (Italy)
SECOND SESSION
Emerging infectious diseases in humans: the INF-ACT project
Carlo Giaquinto (Italy)
Wastewater surveillance for public health
Timothy Julian (Switzerland)
Impact of climate change on the distribution of infectious diseases
Sandro Fuzzi (Italy)
One Health priority research agenda for antimicrobial resistance
Daniele Donà (Italy)
Friday 29 November 2024
FIRST SESSION
Update and management of bronchiolitis
Anna Chiara Vittucci (Italy)
SECOND SESSION
Vaccines in development for the pediatric Population
Hanna Nohynek (Finland)
THIRD SESSION
Where we are going with vaccination of children against influenza
Vana Spoulou (Greece)
Present and future in prevention of pneumococcal disease
David Greenberg (Israel)
FOURTH SESSION
Influenza: navigating from seasonal to pandemic perspectives
Giovanni Rezza (Italy)
COVID-19: insights gained from the global pandemic
Giuseppe Ippolito (Italy)
Mpox and the path to elimination
Rosamund Lewis (Switzerland)
Outbreaks in healthcare settings
Valentina Fainardi (Italy)
Saturday 30 November 2024
FIRST SESSION
Monoclonal antibodies to prevent and treat infections
Natasha Halasa (USA)
SECOND SESSION
Viral eradication: dreams or reality?
Pier Luigi Lo Palco (Italy)
Impact of vaccines on antimicrobial resistance
Chiara Sepulcri (Italy)
How the vaccines work in the immunocompromised Population
Klara Posfay-Barbe (Switzerland)
Big data and engineering to optimize immunization strategies: some preliminary experiences
Juan Pablo Torres (Chile)
